Clearstead Advisors’s Avidity Biosciences RNAM Stock Holding History

Clearstead Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-998	Closed	-$72K	–	2737
2025 Q4	$72K	Buy	+998	New	+$64.5K	﹤0.01%	1241
2025 Q2	–	Sell	-373	Closed	-$11K	–	2855
2025 Q1	$11K	Buy	373 +202	+118%	+$6.29K	﹤0.01%	1588
2024 Q4	$4.97K	Hold	171	–	–	﹤0.01%	1720
2024 Q3	$7.86K	Buy	+171	New	+$7.42K	﹤0.01%	1632

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Clearstead Advisors's RNAM Position: Q1 2026 in Review

Clearstead Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 998 shares — an estimated $72K sold.

Clearstead Advisors first reported a position in RNAM in Q3 2024 and held it in 4 quarters. The position peaked at $72K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Clearstead Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Clearstead Advisors sold 998 Avidity Biosciences shares in Q1 2026, an estimated $72K.
Clearstead Advisors first reported a position in Avidity Biosciences in Q3 2024 and held it in 4 quarters.
Clearstead Advisors's Avidity Biosciences position peaked at $72K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.